- Home
- RIGL vs DDL Comparison
RIGL vs DDL Comparison
Compare RIGL & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RIGL | DDL |
|---|---|---|
| Founded | 1996 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 564.7M | 578.8M |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RIGL | DDL |
|---|---|---|
| Price | $40.45 | $2.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $45.67 | N/A |
| AVG Volume (30 Days) | 386.8K | ★ 570.9K |
| Earning Date | 05-05-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1867.68 | N/A |
| EPS | ★ 0.44 | N/A |
| Revenue | ★ $294,282,000.00 | N/A |
| Revenue This Year | N/A | $7.06 |
| Revenue Next Year | $12.75 | $14.86 |
| P/E Ratio | $93.09 | ★ $16.08 |
| Revenue Growth | ★ 64.15 | N/A |
| 52 Week Low | $18.70 | $1.65 |
| 52 Week High | $52.24 | $3.41 |
Technical Indicators
Market Signals| Indicator | RIGL | DDL |
|---|---|---|
| Relative Strength Index (RSI) | 64.43 | 58.27 |
| Support Level | $40.05 | $1.83 |
| Resistance Level | $44.85 | $2.65 |
| Average True Range (ATR) | 1.82 | 0.10 |
| MACD | -0.04 | 0.06 |
| Stochastic Oscillator | 58.00 | 87.88 |
Price Performance
Historical ComparisonAbout RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.